- Home
- Therapeutics
- Medical Device
Medical Device
91黑料 understands the unique requirements of medical devices, diagnostics and combination drug/device and biologic/device products
91黑料's uses advanced medical technologies and diagnostics for patient treatment, monitoring, and screening
Medical Device therapeutic expertise
91黑料’s medical device team brings a wealth of U.S. FDA, EU, industry, and healthcare expertise. Our therapeutic experience devices and diagnostics with indications in:
- Cardiovascular disease
- Orthopedics
- Diabetes management
- Oncology
- Respiratory
- Dental and maxillofacial
- Blood Banking
Our teams are well-versed in the global regulatory and clinical trial requirements for a full range of medical device and diagnostic products and assist in the application of human factors engineering to product design. Our experience includes:
- Bio-engineered and tissue-engineered products
- Surgical tools, systems, and accessories
- Drug delivery / Drug-Device combination products
- Diagnostic imaging devices and systems
- Medical device software, wireless systems, and mobile medical applications
- OTC and consumer products
- IVDs and companion diagnostics
In this section
In this section
- Biosimilars
-
Cardiovascular
- Cell and Gene Therapies
- Central Nervous System
-
Endocrine & Metabolic Disorders
- Hepatology
- Infectious Diseases
- Internal Medicine & Immunology
-
Medical Device
-
Obesity
- Oncology
-
Pediatrics
- Rare & Orphan Diseases
- Vaccines
-
Women's Health
-
Therapeutics insights
- Biosimilars
- Cardiovascular
- Cell and Gene Therapies
- Central Nervous System
-
Glycomics
- Infectious Diseases
- Hepatology
-
Women's Health Insights
-
Oncology
- Pediatrics
-
Rare and orphan diseases
-
Pushing boundaries in idiopathic pulmonary fibrosis clinical research
-
Advanced therapies for rare diseases
-
Cross-border enrollment of rare disease patients
-
Crossing the finish line: Why effective participation support strategy is critical to trial efficiency and success in rare diseases
-
Diversity, equity and inclusion in rare disease clinical trials
-
Identify and mitigate risks to rare disease clinical programmes
-
Leveraging historical data for use in rare disease trials
-
Natural history studies to improve drug development in rare diseases
-
Patient Centricity in Orphan Drug Development
-
The key to remarkable rare disease registries
-
Pushing boundaries in idiopathic pulmonary fibrosis clinical research